TY - JOUR T1 - Residual SARS-CoV-2 viral antigens detected in gastrointestinal and hepatic tissues from two recovered COVID-19 patients JF - medRxiv DO - 10.1101/2020.10.28.20219014 SP - 2020.10.28.20219014 AU - Chun Chau Lawrence Cheung AU - Denise Goh AU - Xinru Lim AU - Tracy Zhijun Tien AU - Jeffrey Chun Tatt Lim AU - Sanjna Nilesh Nerurkar AU - Loong Shihleone AU - Peng Chung Cheow AU - Chung Yip Chan AU - Ye Xin Koh AU - Thuan Tong Tan AU - Shirin Kalimuddin AU - Wai Meng David Tai AU - Jia Lin Ng AU - Jenny Guek Hong Low AU - Joe Yeong AU - Tony Kiat Hon Lim Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/03/2020.10.28.20219014.abstract N2 - Residual SARS-CoV-2 RNA has been detected in stool samples and gastrointestinal tissues during the convalescence phase of COVID-19 infection. This raises concern for persistence of SARS-CoV-2 virus particles and faecal-oral transmissibility in recovered COVID-19 patients. Using multiplex immunohistochemistry, we unexpectedly detected SARS-CoV-2 viral antigens in intestinal and liver tissues, in surgical samples obtained from two patients who recovered from COVID-19. We further validated the presence of virus by RT-PCR and flow cytometry to detect SARS-CoV-2-specific immunity in the tissues. These findings might have important implications in terms of disease management and public health policy regarding transmission of COVID-19 via faecal-oral and iatrogenic routes during the convalescence phase.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is supported by the Centre Grant of Singapore General Hospital (grant no. NMRC/CG/M011/2017_SGH)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the SingHealth Centralised Institutional Review Board (reference number: 2019/2653).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available from the corresponding authors upon reasonable request. ER -